The purpose of this study was to evaluate the performance of the Drigalski agar supplemented with 2 mg/L of ceftazidime (DC) for selective isolation of expanded-spectrum beta-lactamase (ESBL) producing Enterobacteria in clinical samples. The Drigalski agar supplemented with 2 mg/L of ceftazidime was compared with the chromID TM ESBL medium (bioMérieux, Marcy l'Etoile, France). Six strains from the collection of reference center for antibiotics of the Pasteur Institute of Paris and 247 clinical samples were used to calculate the performance and the intrinsic characteristics of DC medium, respectively. The main ESBL producing Enterobacteria consist of Escherichia coli (n = 31; 44.3%), Klebsiella pneumoniae (n = 19; 27.1%) and Enterobacter cloacae (n = 12; 17.1%). ESBL producers were confirmed by synergy testing. The sensitivity (Se), specificity (Sp), positive predictive value (PPV) and negative predictive value (PPN) after 24 h of incubation at 37°C were respectively 98.6, 98.7, 98.6 and 98.7%. The study shows that DC agar is a sensitive and specific medium for selective isolation of ESBL producing Enterobacteria, but the character chromogenic agar chromID TM ESBL remains an additional advantage in the identification of strains.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.